Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156858
Status:
UNKNOWN
Last Update Posted:
2012-01-19
First Post:
2005-09-08
Brief Title:
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation a Pharmacokinetic Study
Sponsor:
Alberta Health services
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell
Status:
UNKNOWN
Status Verified Date:
2011-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study of pharmacokinetics of daily intravenous busulfan
Detailed Description:
A study of pharmacokinetics of daily intravenous busulfan
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 717905172 | None | None | None |